...
search icon
spro-img

Spero Therapeutics Inc Share Price

SPRO
NSQ
$2.33
-$0.02
(-0.85%)
1D
Industry: Biotechnology Sector: Health Care

Spero Therapeutics Inc Analyst Forecast

Spero Therapeutics Inc Share Price Chart

Spero Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$132.40M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
266.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.45
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.51 L
$3.22 H
$2.33

About Spero Therapeutics Inc, Common Stock

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candidate for first-line treatment of nontuberculous mycobacterial (NTM) pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to the oral prodrug SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Spero Therapeutics Inc Stock Returns

Time FrameSPROSectorS&P500
1-Week Return-1.69%0.72%-1.31%
1-Month Return-2.1%1.27%0.78%
3-Month Return-5.67%3.13%3.46%
6-Month Return21.99%15.81%6.19%
1-Year Return183.77%8.89%11.68%
3-Year Return40.36%20.79%71.21%
5-Year Return-88.47%35.89%74.81%
10-Year Return-79.74%138.44%256.59%

Spero Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue9.33M3.07M48.58M103.78M47.98M[{"date":"2020-12-31","value":8.99,"profit":true},{"date":"2021-12-31","value":2.96,"profit":true},{"date":"2022-12-31","value":46.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":46.23,"profit":true}]
Cost of Revenue67.00M1.12M1.55M51.44M96.76M[{"date":"2020-12-31","value":69.25,"profit":true},{"date":"2021-12-31","value":1.15,"profit":true},{"date":"2022-12-31","value":1.6,"profit":true},{"date":"2023-12-31","value":53.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit9.33M3.07M48.58M52.34M(48.78M)[{"date":"2020-12-31","value":17.83,"profit":true},{"date":"2021-12-31","value":5.87,"profit":true},{"date":"2022-12-31","value":92.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-93.2,"profit":false}]
Gross Margin100.00%100.00%100.00%50.43%(101.67%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":50.43,"profit":true},{"date":"2024-12-31","value":-101.67,"profit":false}]
Operating Expenses88.44M91.04M90.78M30.86M24.58M[{"date":"2020-12-31","value":97.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.71,"profit":true},{"date":"2023-12-31","value":33.9,"profit":true},{"date":"2024-12-31","value":27,"profit":true}]
Operating Income(79.11M)(87.97M)(42.20M)21.48M(73.36M)[{"date":"2020-12-31","value":-368.29,"profit":false},{"date":"2021-12-31","value":-409.53,"profit":false},{"date":"2022-12-31","value":-196.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-341.52,"profit":false}]
Total Non-Operating Income/Expense1.23M(3.38M)(5.72M)7.86M9.53M[{"date":"2020-12-31","value":12.95,"profit":true},{"date":"2021-12-31","value":-35.46,"profit":false},{"date":"2022-12-31","value":-59.99,"profit":false},{"date":"2023-12-31","value":82.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(78.28M)(89.76M)(46.41M)25.40M(68.57M)[{"date":"2020-12-31","value":-308.14,"profit":false},{"date":"2021-12-31","value":-353.31,"profit":false},{"date":"2022-12-31","value":-182.71,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-269.9,"profit":false}]
Income Taxes(761.00K)1.54M1.61M2.60M-[{"date":"2020-12-31","value":-29.29,"profit":false},{"date":"2021-12-31","value":59.47,"profit":true},{"date":"2022-12-31","value":62.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(77.52M)(91.30M)(48.03M)22.81M-[{"date":"2020-12-31","value":-339.91,"profit":false},{"date":"2021-12-31","value":-400.34,"profit":false},{"date":"2022-12-31","value":-210.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(78.28M)(89.76M)(46.41M)22.81M(68.57M)[{"date":"2020-12-31","value":-343.24,"profit":false},{"date":"2021-12-31","value":-393.56,"profit":false},{"date":"2022-12-31","value":-203.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-300.65,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(77.52M)(89.76M)(46.41M)22.81M(68.57M)[{"date":"2020-12-31","value":-339.91,"profit":false},{"date":"2021-12-31","value":-393.56,"profit":false},{"date":"2022-12-31","value":-203.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-300.65,"profit":false}]
EPS (Diluted)(3.58)(2.89)(1.66)0.52(1.26)[{"date":"2020-12-31","value":-688.46,"profit":false},{"date":"2021-12-31","value":-555.77,"profit":false},{"date":"2022-12-31","value":-319.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-241.71,"profit":false}]

Spero Therapeutics Inc Ratios

Spero Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SPRO
Cash Ratio 3.56
Current Ratio 3.83

Spero Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SPRO
ROA (LTM) -29.77%
ROE (LTM) -95.30%

Spero Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SPRO
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Spero Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SPRO
Trailing PE NM
Forward PE NM
P/S (TTM) 3.27
P/B 5.10
Price/FCF 8
EV/R 3.07
EV/Ebitda 0.75
PEG NM

FAQs

What is Spero Therapeutics Inc share price today?

Spero Therapeutics Inc (SPRO) share price today is $2.33

Can Indians buy Spero Therapeutics Inc shares?

Yes, Indians can buy shares of Spero Therapeutics Inc (SPRO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SPRO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Spero Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Spero Therapeutics Inc (SPRO) via the Vested app. You can start investing in Spero Therapeutics Inc (SPRO) with a minimum investment of $1.

How to invest in Spero Therapeutics Inc shares from India?

You can invest in shares of Spero Therapeutics Inc (SPRO) via Vested in three simple steps:

  • Click on Sign Up or Invest in SPRO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Spero Therapeutics Inc shares
What is Spero Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Spero Therapeutics Inc (SPRO) is $3.22. The 52-week low price of Spero Therapeutics Inc (SPRO) is $0.51.

What is Spero Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Spero Therapeutics Inc (SPRO) is

What is Spero Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Spero Therapeutics Inc (SPRO) is 5.10

What is Spero Therapeutics Inc dividend yield?

The dividend yield of Spero Therapeutics Inc (SPRO) is 0.00%

What is the Market Cap of Spero Therapeutics Inc?

The market capitalization of Spero Therapeutics Inc (SPRO) is $132.40M

What is Spero Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Spero Therapeutics Inc is SPRO

How Can Investors Use Spero Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Spero Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Spero Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Spero Therapeutics Inc shares for Indian investors?

When investing in Spero Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Spero Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Spero Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Spero Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Spero Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top